X

Godrej Consumer Products Limited (GODREJCP) Q3 2026 Earnings Call Transcript

Godrej Consumer Products Limited (NSE: GODREJCP) Q3 2026 Earnings Call dated Jan. 23, 2026 Corporate Participants: Vishal Kedia — Investor…

Sterlite Technologies Ltd (STLTECH) Q3 2026 Earnings Call Transcript

Sterlite Technologies Ltd (NSE: STLTECH) Q3 2026 Earnings Call dated Jan. 23, 2026 Corporate Participants: Ankit Agarwal — Managing Director…

SG Mart Ltd (KRL) Q3 2026 Earnings Call Transcript

SG Mart Ltd (NSE: KRL) Q3 2026 Earnings Call dated Jan. 23, 2026 Corporate Participants: Anubhav Gupta — Group Chief…

D. P. Abhushan Q3 FY2026 Results Show Strong Revenue and Profit Growth

D. P. Abhushan Limited (NSE: DPABHUSHAN, BSE: 544161) reported its financial results for the third quarter of fiscal year 2026,…

UltraTech Cement Q3 profit beats estimates on robust infrastructure demand

UltraTech Cement Ltd (NSE: ULTRACEMCO) reported a 27% increase in consolidated net profit for the December quarter, surpassing analyst expectations…

UltraTech Cement Reports 23% Revenue Growth in Q3 FY26 as Capacity Reaches 194 MTPA

Growth Accelerates with Scale Advantage Aditya Birla Group's flagship cement producer recorded consolidated net sales of ₹21,506 crore and improved…

D.P. Abhushan Limited: Strategic Resilience and Profitability in a Dynamic Jewelry Market

In an era where the Indian jewelry sector is navigating the twin challenges of record-high gold prices and shifting consumer…

D.P. Abhushan Limited: Scaling New Heights Amidst Market Volatility

D.P. Abhushan Limited (NSE: DPABHUSHAN), a premier name in the Indian retail jewelry sector, has once again demonstrated its operational…

OneSource Specialty Pharma Ltd operational scale expands amid near-term earnings volatility

OneSource Specialty Pharma Ltd (BSE: 544292 / NSE: ONESOURCE) has emerged as a multi-modality contract development and manufacturing organisation (CDMO)…

OneSource Specialty Pharma Ltd reports Q3 FY26 revenue of ₹2.9 billion, EBITDA declines amid approval delays

OneSource Specialty Pharma Ltd (BSE: 544292 / NSE: ONESOURCE) reported consolidated revenue of ₹2.9 billion for the quarter ended December…